The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ACHIEVE LIFE SCIENCES INC | COM | 004468500 | 3,797,211 | 835,470 | SH | SOLE | 835,470 | 0 | 0 | ||
ADMA BIOLOGICS INC | COM | 000899104 | 10,164,000 | 1,540,000 | SH | SOLE | 1,540,000 | 0 | 0 | ||
ADVISORSHARES TR | CALL | 00768Y903 | 11,261,250 | 1,125,000 | SH | Call | SOLE | 1,125,000 | 0 | 0 | |
ALIMERA SCIENCES INC | COM NEW | 016259202 | 9,945,000 | 2,550,000 | SH | SOLE | 2,550,000 | 0 | 0 | ||
ALPINE IMMUNE SCIENCES INC | COM | 02083G100 | 3,085,895 | 77,848 | SH | SOLE | 77,848 | 0 | 0 | ||
AQUESTIVE THERAPEUTICS INC | COM | 03843E104 | 2,832,900 | 665,000 | SH | SOLE | 665,000 | 0 | 0 | ||
ASCENDIS PHARMA A/S | SPONSORED ADR | 04351P101 | 3,779,250 | 25,000 | SH | SOLE | 25,000 | 0 | 0 | ||
ASTRIA THERAPEUTICS INC | COM | 04635X102 | 2,006,138 | 142,532 | SH | SOLE | 142,532 | 0 | 0 | ||
AVADEL PHARMACEUTICALS PLC | SPONSORED ADR | 05337M104 | 9,341,133 | 553,057 | SH | SOLE | 553,057 | 0 | 0 | ||
AXSOME THERAPEUTICS INC | COM | 05464T104 | 11,012,400 | 138,000 | SH | SOLE | 138,000 | 0 | 0 | ||
AZITRA INC | COM | 05479L104 | 101,343 | 493,153 | SH | SOLE | 493,153 | 0 | 0 | ||
BIOHAVEN LTD | COM | G1110E107 | 7,656,600 | 140,000 | SH | SOLE | 140,000 | 0 | 0 | ||
BIOVIE INC | CL A NEW | 09074F207 | 1,592,465 | 3,012,608 | SH | SOLE | 3,012,608 | 0 | 0 | ||
BITCOIN DEPOT INC | *W EXP 06/30/202 | 09174P113 | 4,745 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
BOUNDLESS BIO INC | COM | 10170A100 | 2,850,000 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
BRUUSH ORAL CARE INC | *W EXP 08/03/202 | 11750K120 | 110 | 14,423 | SH | SOLE | 14,423 | 0 | 0 | ||
CATALYST PHARMACEUTICALS INC | COM | 14888U101 | 7,970,000 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||
CEA INDUSTRIES INC | *W EXP 02/11/202 | 86887P119 | 3,250 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
CINGULATE INC | *W EXP 12/10/202 | 17248W113 | 5,697 | 270,000 | SH | SOLE | 270,000 | 0 | 0 | ||
COLISEUM ACQUISITION CORP | *W EXP 08/22/202 | G2263T107 | 1,870 | 28,333 | SH | SOLE | 28,333 | 0 | 0 | ||
CONDUIT PHARMACEUTICALS INC | *W EXP 09/22/202 | 20678X114 | 6,000 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
CYBIN INC | COM | 23256X100 | 5,769,767 | 13,953,488 | SH | SOLE | 13,953,488 | 0 | 0 | ||
DIGITAL HEALTH ACQUISITION C | *W EXP 99/99/999 | 253893119 | 19,245 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
EVOKE PHARMA INC | COM NEW | 30049G203 | 442,215 | 724,942 | SH | SOLE | 724,942 | 0 | 0 | ||
FAT BRANDS INC | *W EXP 07/16/202 | 30258N121 | 974,000 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
GERON CORP | CALL | 374163903 | 1,320,000 | 400,000 | SH | Call | SOLE | 400,000 | 0 | 0 | |
GRI BIO INC | COM NEW | 3622AW205 | 142,866 | 187,981 | SH | SOLE | 187,981 | 0 | 0 | ||
INSMED INC | COM PAR $.01 | 457669307 | 3,255,600 | 120,000 | SH | SOLE | 120,000 | 0 | 0 | ||
INTRA-CELLULAR THERAPIES INC | COM | 46116X101 | 7,819,600 | 113,000 | SH | SOLE | 113,000 | 0 | 0 | ||
JEFFS BRANDS LTD | *W EXP 99/99/999 | M61472110 | 4,011 | 68,681 | SH | SOLE | 68,681 | 0 | 0 | ||
KARYOPHARM THERAPEUTICS INC | COM | 48576U106 | 1,117,400 | 740,000 | SH | SOLE | 740,000 | 0 | 0 | ||
LARIMAR THERAPEUTICS INC | COM | 517125100 | 5,275,050 | 695,000 | SH | SOLE | 695,000 | 0 | 0 | ||
LONGBOARD PHARMACEUTICALS IN | COM | 54300N103 | 3,672,000 | 170,000 | SH | SOLE | 170,000 | 0 | 0 | ||
MARINUS PHARMACEUTICALS INC | COM NEW | 56854Q200 | 1,598,634 | 176,840 | SH | SOLE | 176,840 | 0 | 0 | ||
MILESTONE PHARMACEUTICALS IN | COM | 59935V107 | 2,171,059 | 1,212,882 | SH | SOLE | 1,212,882 | 0 | 0 | ||
MIRUM PHARMACEUTICALS INC | COM | 604749101 | 5,224,960 | 208,000 | SH | SOLE | 208,000 | 0 | 0 | ||
MOBILICOM LTD | SPON ADS | 60742B102 | 160,997 | 135,292 | SH | SOLE | 135,292 | 0 | 0 | ||
MOBIX LABS INC | *W EXP 99/99/999 | 60743G118 | 31,500 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
NEUROGENE INC | COM | 64135M105 | 5,090,000 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
NEXALIN TECHNOLOGY INC | *W EXP 99/99/999 | 65345B110 | 4,389 | 105,000 | SH | SOLE | 105,000 | 0 | 0 | ||
NEXGEL INC | *W EXP 12/01/202 | 65344E115 | 162,000 | 225,000 | SH | SOLE | 225,000 | 0 | 0 | ||
NLS PHARMACEUTICS LTD | *W EXP 02/02/202 | H57830111 | 6,880 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
NOCTURNE ACQUISITION CORP | RIGHT 12/26/2025 | G6580S106 | 82,000 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||
OLEMA PHARMACEUTICALS INC | COM | 68062P106 | 6,848,600 | 605,000 | SH | SOLE | 605,000 | 0 | 0 | ||
ONFOLIO HOLDINGS INC | *W EXP 01/02/202 | 68277K124 | 8,120 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
ORIC PHARMACEUTICALS INC | COM | 68622P109 | 5,568,750 | 405,000 | SH | SOLE | 405,000 | 0 | 0 | ||
PERFECT MOMENT LTD | COM SHS | 713715100 | 330,105 | 92,208 | SH | SOLE | 92,208 | 0 | 0 | ||
PERSPECTIVE THERAPEUTICS INC | COM | 46489V104 | 637,432 | 535,657 | SH | SOLE | 535,657 | 0 | 0 | ||
PRAXIS PRECISION MEDICINES I | COM NEW | 74006W207 | 4,765,662 | 78,100 | SH | SOLE | 78,100 | 0 | 0 | ||
PROSOMNUS INC | *W EXP 04/20/202 | 50535E116 | 3,000 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
QUOIN PHARMACEUTICALS LTD | SPONSORED ADS | 74907L300 | 62,928 | 66,240 | SH | SOLE | 66,240 | 0 | 0 | ||
RAPT THERAPEUTICS INC | CALL | 75382E909 | 1,796,000 | 200,000 | SH | Call | SOLE | 200,000 | 0 | 0 | |
RELATIVITY ACQUISITION CORP | *W EXP 12/15/202 | 75944B114 | 0 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
RHYTHM PHARMACEUTICALS INC | COM | 76243J105 | 2,481,552 | 57,271 | SH | SOLE | 57,271 | 0 | 0 | ||
ROCKET PHARMACEUTICALS INC | *W EXP 09/02/202 | 77313F114 | 218,883 | 731,561 | SH | SOLE | 731,561 | 0 | 0 | ||
SAVARA INC | COM | 805111101 | 6,648,300 | 1,335,000 | SH | SOLE | 1,335,000 | 0 | 0 | ||
SELINA HOSPITALITY PLC | *W EXP 10/27/202 | G8059B119 | 710 | 101,439 | SH | SOLE | 101,439 | 0 | 0 | ||
SOLENO THERAPEUTICS INC | COM | 834203309 | 6,544,505 | 152,909 | SH | SOLE | 152,909 | 0 | 0 | ||
SPRUCE BIOSCIENCES INC | COM | 85209E109 | 903,785 | 1,150,000 | SH | SOLE | 1,150,000 | 0 | 0 | ||
SURROZEN INC | *W EXP 08/01/203 | 86889P117 | 3,404 | 82,233 | SH | SOLE | 82,233 | 0 | 0 | ||
TC BIOPHARM HOLDINGS PLC | *W EXP 02/10/202 | 87807D111 | 376 | 18,823 | SH | SOLE | 18,823 | 0 | 0 | ||
THE REALREAL INC | COM | 88339P101 | 3,128,000 | 800,000 | SH | SOLE | 800,000 | 0 | 0 | ||
TOURMALINE BIO INC | COM | 89157D105 | 1,498,622 | 65,442 | SH | SOLE | 65,442 | 0 | 0 | ||
VERA THERAPEUTICS INC | CL A | 92337R101 | 30,615,200 | 710,000 | SH | SOLE | 710,000 | 0 | 0 | ||
VERU INC | COM | 92536C103 | 1,478,423 | 2,111,731 | SH | SOLE | 2,111,731 | 0 | 0 | ||
VIKING THERAPEUTICS INC | COM | 92686J106 | 6,970,000 | 85,000 | SH | SOLE | 85,000 | 0 | 0 | ||
VIKING THERAPEUTICS INC | PUT | 92686J956 | 14,374,600 | 175,300 | SH | Put | SOLE | 175,300 | 0 | 0 | |
WEARABLE DEVICES LTD | *W EXP 09/14/202 | M97838110 | 109,470 | 1,411,600 | SH | SOLE | 1,411,600 | 0 | 0 | ||
WESTERN ACQSTN VENTURES CORP | *W EXP 99/99/999 | 95758L115 | 4,275 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
XENON PHARMACEUTICALS INC | COM | 98420N105 | 14,981,400 | 348,000 | SH | SOLE | 348,000 | 0 | 0 | ||
XTANT MED HLDGS INC | COM NEW | 98420P308 | 8,948,011 | 7,647,873 | SH | SOLE | 7,647,873 | 0 | 0 | ||
ZEVRA THERAPEUTICS INC | COM NEW | 488445206 | 1,980,474 | 341,461 | SH | SOLE | 341,461 | 0 | 0 |